JP2022505585A5 - - Google Patents
Info
- Publication number
- JP2022505585A5 JP2022505585A5 JP2021521976A JP2021521976A JP2022505585A5 JP 2022505585 A5 JP2022505585 A5 JP 2022505585A5 JP 2021521976 A JP2021521976 A JP 2021521976A JP 2021521976 A JP2021521976 A JP 2021521976A JP 2022505585 A5 JP2022505585 A5 JP 2022505585A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- amino acid
- acid sequence
- alk2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024102779A JP2024114820A (ja) | 2018-10-23 | 2024-06-26 | Ａｌｋ２抗体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862749463P | 2018-10-23 | 2018-10-23 | |
| US62/749,463 | 2018-10-23 | ||
| PCT/US2019/057679 WO2020086730A1 (en) | 2018-10-23 | 2019-10-23 | Alk2 antibodies and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102779A Division JP2024114820A (ja) | 2018-10-23 | 2024-06-26 | Ａｌｋ２抗体及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505585A JP2022505585A (ja) | 2022-01-14 |
| JP2022505585A5 true JP2022505585A5 (https=) | 2022-10-18 |
| JP7512272B2 JP7512272B2 (ja) | 2024-07-08 |
Family
ID=70331231
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521976A Active JP7512272B2 (ja) | 2018-10-23 | 2019-10-23 | Ａｌｋ２抗体及びその使用方法 |
| JP2024102779A Pending JP2024114820A (ja) | 2018-10-23 | 2024-06-26 | Ａｌｋ２抗体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102779A Pending JP2024114820A (ja) | 2018-10-23 | 2024-06-26 | Ａｌｋ２抗体及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12331124B2 (https=) |
| EP (1) | EP3870613A4 (https=) |
| JP (2) | JP7512272B2 (https=) |
| KR (1) | KR102919834B1 (https=) |
| CN (2) | CN113366019B (https=) |
| AU (1) | AU2019364415A1 (https=) |
| BR (1) | BR112021007660A2 (https=) |
| CA (1) | CA3116900A1 (https=) |
| IL (1) | IL282424A (https=) |
| WO (1) | WO2020086730A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3870181B1 (en) | 2018-10-26 | 2024-08-14 | Keros Therapeutics, Inc. | Crystal forms of an alk2 inhibitor |
| US20220372135A1 (en) | 2019-09-27 | 2022-11-24 | Disc Medicine, Inc. | Methods for treating myelofibrosis and related conditions |
| KR20220140802A (ko) | 2020-02-11 | 2022-10-18 | 리제너론 파아마슈티컬스, 인크. | 항-acvr1 항체 및 이의 용도 |
| US12508262B2 (en) | 2020-04-30 | 2025-12-30 | Keros Therapeutics, Inc. | Methods of using ALK2 inhibitors |
| KR20230012539A (ko) | 2020-05-13 | 2023-01-26 | 디스크 메디슨, 인크. | 골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체 |
| WO2022098812A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating iron overload |
| US20250282877A1 (en) * | 2021-05-11 | 2025-09-11 | Keros Therapeutics, Inc. | Methods of using alk2 and alk3 antibodies |
| US20250034148A1 (en) * | 2021-11-02 | 2025-01-30 | Keros Therapeutics, Inc. | Methods of using alk2 inhibitors |
| WO2024092133A1 (en) * | 2022-10-27 | 2024-05-02 | Regeneron Pharmaceuticals, Inc. | Anti-acvr1 antibodies and their use in the treatment of trauma-induced heterotopic ossification |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2570458C (en) * | 2004-06-09 | 2014-05-20 | Technion Research & Development Foundation Ltd. | Antibodies for selective apoptosis of cells |
| CA2662350A1 (en) | 2006-09-05 | 2008-03-13 | Medarex, Inc. | Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| JP5755635B2 (ja) | 2009-03-30 | 2015-07-29 | アクセルロン ファーマ， インコーポレイテッド | Ｂｍｐ−ａｌｋ３アンタゴニストおよび骨成長促進のためのその使用 |
| WO2011116212A2 (en) | 2010-03-17 | 2011-09-22 | Oncomed Pharmaceuticals, Inc. | Bone morphogenetic protein receptor binding agents and methods of their use |
| WO2012065059A2 (en) | 2010-11-12 | 2012-05-18 | The General Hospital Corporation | Treatment of atherosclerosis with bmp-alk3 antagonists |
| JP6601687B2 (ja) * | 2014-03-31 | 2019-11-06 | 大日本住友製薬株式会社 | 進行性骨化性線維異形成症の予防剤及び治療剤 |
| US20160075772A1 (en) * | 2014-09-12 | 2016-03-17 | Regeneron Pharmaceuticals, Inc. | Treatment of Fibrodysplasia Ossificans Progressiva |
| TWI703156B (zh) * | 2015-01-30 | 2020-09-01 | 學校法人埼玉醫科大學 | 抗ａｌｋ２抗體 |
| WO2016154572A1 (en) * | 2015-03-26 | 2016-09-29 | Vanderbilt University | Antibody-mediated neutralizaton of ebolaviruses |
| WO2020118011A1 (en) | 2018-12-06 | 2020-06-11 | Alexion Pharmaceuticals, Inc. | Anti-alk2 antibodies and uses thereof |
| KR20220140802A (ko) | 2020-02-11 | 2022-10-18 | 리제너론 파아마슈티컬스, 인크. | 항-acvr1 항체 및 이의 용도 |
| WO2021257532A1 (en) | 2020-06-16 | 2021-12-23 | Incyte Corporation | Alk2 inhibitors for the treatment of anemia |
| WO2022098812A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating iron overload |
| WO2022098821A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating lymphopenia |
| WO2022099166A1 (en) | 2020-11-09 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating cardiovascular-related disease |
| US20250282877A1 (en) | 2021-05-11 | 2025-09-11 | Keros Therapeutics, Inc. | Methods of using alk2 and alk3 antibodies |
-
2019
- 2019-10-23 CN CN201980085459.7A patent/CN113366019B/zh active Active
- 2019-10-23 WO PCT/US2019/057679 patent/WO2020086730A1/en not_active Ceased
- 2019-10-23 BR BR112021007660-3A patent/BR112021007660A2/pt unknown
- 2019-10-23 AU AU2019364415A patent/AU2019364415A1/en active Pending
- 2019-10-23 KR KR1020217015329A patent/KR102919834B1/ko active Active
- 2019-10-23 CA CA3116900A patent/CA3116900A1/en active Pending
- 2019-10-23 CN CN202411099364.XA patent/CN118955715A/zh active Pending
- 2019-10-23 EP EP19877108.1A patent/EP3870613A4/en active Pending
- 2019-10-23 JP JP2021521976A patent/JP7512272B2/ja active Active
-
2021
- 2021-04-19 IL IL282424A patent/IL282424A/en unknown
- 2021-04-22 US US17/237,240 patent/US12331124B2/en active Active
-
2024
- 2024-06-26 JP JP2024102779A patent/JP2024114820A/ja active Pending
-
2025
- 2025-05-14 US US19/207,888 patent/US20250270333A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022505585A5 (https=) | ||
| JP2022105138A5 (https=) | ||
| JP2021536244A5 (https=) | ||
| JP2019511911A5 (https=) | ||
| JP2020537644A5 (https=) | ||
| JP5047996B2 (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| Greig et al. | Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques | |
| JP2020536888A5 (https=) | ||
| JP2022502371A5 (https=) | ||
| JPWO2020059847A5 (https=) | ||
| JP2005503789A5 (https=) | ||
| JP2019505527A5 (https=) | ||
| JP2022530404A5 (https=) | ||
| JP2021520393A5 (https=) | ||
| JP2017500018A5 (https=) | ||
| JP2023505492A5 (https=) | ||
| JP2018502050A5 (https=) | ||
| JPWO2019156137A5 (https=) | ||
| JP2008525033A5 (https=) | ||
| JP2016524463A5 (https=) | ||
| CN111542343A (zh) | 抗bcma的单域抗体及其应用 | |
| JP2017113019A5 (https=) | ||
| JP2019031567A5 (https=) | ||
| JP2018504112A5 (https=) | ||
| JP2022531556A5 (https=) |